Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease

Description

Remote healthcare monitoring for cirrhosis has shown promise in overcoming barriers to accessing specialty care, improving healthcare quality, and reducing mortality. The LiverWatch study is investigating whether a remote nutrition, physical activity, and education intervention can improve health outcomes in those with cirrhosis. In this clinical trial, individuals will be randomized to either enhanced usual care or the LiverWatch intervention. Both groups are given fitbits and asked to increase their step counts. Those in the Liverwatch group will be incentivized for increase their physical activity while also undergoing a personalized nutrition intervention and weekly symptom monitoring and cirrhosis education.

Conditions

Cirrhosis, Liver, End Stage Liver DIsease, Symptoms and Signs, Physical Inactivity, Muscle Loss

Talk to us

Study Overview

On this page

Study Details

Study overview

Remote healthcare monitoring for cirrhosis has shown promise in overcoming barriers to accessing specialty care, improving healthcare quality, and reducing mortality. The LiverWatch study is investigating whether a remote nutrition, physical activity, and education intervention can improve health outcomes in those with cirrhosis. In this clinical trial, individuals will be randomized to either enhanced usual care or the LiverWatch intervention. Both groups are given fitbits and asked to increase their step counts. Those in the Liverwatch group will be incentivized for increase their physical activity while also undergoing a personalized nutrition intervention and weekly symptom monitoring and cirrhosis education.

Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease

Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease

Condition
Cirrhosis, Liver
Intervention / Treatment

-

Contacts and Locations

Ann Arbor

University of Michigan, Ann Arbor, Michigan, United States, 48109

Philadelphia

University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * English speaking
  • * Aged 18 years or older
  • * Home-dwelling
  • * Diagnosis of cirrhosis- Child Turcotte-Pugh (CTP) B or C or a complication in the past 6 months (CTP B or higher, hepatic encephalopathy, variceal bleeding, fluid overload, liver-related hospitalization, or requiring symptom management with diuretics, non-absorbable disaccharides, rifaximin, nonselective beta blockers)
  • * Patient and/or caregiver is able and willing to receive SMS text messages
  • * Willing and able to wear personal fitness trackers and engage with study staff
  • * No access to a smartphone
  • * Non-home dwelling
  • * On hospice care
  • * Model for end stage liver disease (MELD) score ≥30
  • * Advanced hepatocellular carcinoma, BCLC C or higher
  • * Hospitalization within the last 30 days
  • * Deemed not appropriate by treating physician for medical reasons
  • * Enrolled in other dietary or physical activity interventions
  • * Receiving physical therapy as standard of care

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pennsylvania,

Study Record Dates

2026-05-31